Securities Antitrust Consumer Fraud Structured Finance Whistleblower/Qui Tam Corporate Governance Mergers & Acquisitions ERISA Healthcare Fraud
PartnersOf Counsel Associates Staff Attorneys All
M & A Investigations New Federal Securities Cases Current CasesSettlements & Class Notices Accolades
Our Institutional Monitoring Service Our ProcessReporting Custom Monitoring
Articles Press Releases Television
Contact Us Join a Class Action Report a Fraud

New Federal Securities Cases

PetMed Express, Inc.

A class action lawsuit has been filed in the United States District Court for the Southern District of Florida against PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ: PETS), on behalf of all persons or entities who acquired PetMed securities during the period from May 8, 2017 through August 23, 2017 (the "Class Period"). The lawsuit seeks to recover damages for investors under the federal securities laws.

According to the lawsuit, defendants failed to disclose that: (1) PetMed was marketing dangerous and addictive animal drugs to humans; (2) as such, PetMed is vulnerable to potential civil or criminal liability, as well as other regulatory action; and (3) in turn, Google may halt PetMed's advertising activities.

On August 23, 2017, Aurelius Value published a report alleging that the Company targets opioid users with Google ads and other marketing techniques to facilitate the abuse of opiates. On this news, the Company's stock price fell from $39.41 to $36.22 per share, damaging investors.

If you acquired PetMed securities during the Class Period, you may, no later than October 24, 2017, request the court to appoint you lead plaintiff of the class. Although your ability to share in any recovery is not affected by the decision whether or not to seek appointment as a lead plaintiff, lead plaintiffs make important decisions that could affect the overall recovery for class members, including decisions concerning settlement.

If you are a current or former PetMed shareholder and wish to obtain additional information, please fill out the contact form at the link below.

Investigation Contact Form

PetMed Express, Inc. Contact Form


Ira M. Press

Kirby McInerney LLP | 825 Third Avenue | NYC 10022 | Tel. 212.371.6600 | Fax 212.751.2540

Attorney Advertising - Prior Results do not Guarantee a Similar Outcome

Law Firm Web Design by Business Edge